No records
|
831 |
55703138400 |
Instiaty |
dr. Instiaty, Sp.FK., Ph.D. |
Departemen Farmakologi dan Terapeutik |
Farmakologi Klinik (Sp-1) |
Outcomes of Daily Dose versus Part-daily Dose Treatment for Lung Tuberculosis: A Real-World Database Study in an Indonesian Hospital |
2021 |
William W., Ascobat P., Instiaty I., Agustin H. |
Acta medica Indonesiana |
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103993218&partnerID=40&md5=8b5b59f2fda6442613cb3b59085dcbde |
321 |
Q3 |
14162 |
|
|
873 |
55703138400 |
Instiaty |
dr. Instiaty, Sp.FK., Ph.D. |
Departemen Farmakologi dan Terapeutik |
Farmakologi Klinik (Sp-1) |
Tpmt genetic variability and its association with hematotoxicity in indonesian children with acute lymphoblastic leukemia in maintenance therapy |
2021 |
Rosdiana D.S., Setiabudy R., Andalusia R., Gatot D., Louisa M., Bardosono S., Instiaty I. |
Pharmacogenomics and Personalized Medicine |
2 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101168492&doi=10.2147%2fPGPM.S288988&partnerID=40&md5=45069dfc59e995d12723c15428e48bcd |
845 |
Q2 |
5609 |
|
|
706 |
6602316235 |
Rianto Setiabudy |
Prof. Dr. dr. Rianto Setiabudy, SpFK |
Departemen Farmakologi dan Terapeutik |
Ilmu Kedokteran (S3) |
Tgf-β-induced tmepai promotes epithelial– mesenchymal transition in doxorubicin-treated triple-negative breast cancer cells via smad3 and pi3k/akt pathway alteration |
2021 |
Wardhani B.W.K., Louisa M., Watanabe Y., Setiabudy R., Kato M. |
Breast Cancer: Targets and Therapy |
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85115827526&doi=10.2147%2fBCTT.S325429&partnerID=40&md5=0fe888a00b703b194e1cca6235180684 |
1190 |
Q2 |
3344 |
|
|
780 |
6602316235 |
Rianto Setiabudy |
Prof. Dr. dr. Rianto Setiabudy, SpFK |
Departemen Farmakologi dan Terapeutik |
Ilmu Kedokteran (S3) |
Comparison of Light Transmission Aggregometry and VerifyNow in Detecting Clopidogrel Resistance and Factors Affecting Clopidogrel Resistance in AMI-EST Patients Undergoing Percutaneous Coronary Intervention: A Cross-Sectional Study |
2021 |
Giantini A., Timan I.S., Listiyaningsih E., Dharma R., Setiabudy R., Alwi I., Partakusuma L.G., Indrasari N.D., Harahap· A.R., Suparmin· S., Sahar W., Sukmawan R. |
Indonesian Biomedical Journal |
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85108601516&doi=10.18585%2finabj.v13i2.1477&partnerID=40&md5=2ade19315f56303e4e2ab7f2428ec652 |
160 |
Q4 |
22228 |
|
|
785 |
6602316235 |
Rianto Setiabudy |
Prof. Dr. dr. Rianto Setiabudy, SpFK |
Departemen Farmakologi dan Terapeutik |
Ilmu Kedokteran (S3) |
Melatonin effect on hypoxia inducible factor-1a and clinical response in patients with oral squamous cell carcinoma receiving neoadjuvant chemotherapy: A randomized controlled trial |
2021 |
Kartini D., Taher A., Panigoro S., Setiabudy R., Jusman S., Haryana S., Murdani A., Rustamadji P., Karisyah A., Rasyid S. |
Journal of Carcinogenesis |
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85108295574&doi=10.4103%2fjcar.JCar_19_20&partnerID=40&md5=7ba744b8de3c6ab6a11dd7b89d27e34a |
2771 |
Q1 |
735 |
|
|
873 |
6602316235 |
Rianto Setiabudy |
Prof. Dr. dr. Rianto Setiabudy, SpFK |
Departemen Farmakologi dan Terapeutik |
Ilmu Kedokteran (S3) |
Tpmt genetic variability and its association with hematotoxicity in indonesian children with acute lymphoblastic leukemia in maintenance therapy |
2021 |
Rosdiana D.S., Setiabudy R., Andalusia R., Gatot D., Louisa M., Bardosono S., Instiaty I. |
Pharmacogenomics and Personalized Medicine |
2 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101168492&doi=10.2147%2fPGPM.S288988&partnerID=40&md5=45069dfc59e995d12723c15428e48bcd |
845 |
Q2 |
5609 |
|
|
882 |
8521176100 |
Nafrialdi |
dr. Nafrialdi, Ph.D., SpPD |
Departemen Farmakologi dan Terapeutik |
Farmakologi Klinik (Sp-1) |
Development of a module for the prevention of nonsteroidal anti-inflammatory drugs-associated gastrointestinal adverse reactions in the elderly at a primary health center |
2021 |
Siregar A.S., Werdhani R.A., Ascobat P., Nafrialdi N., Syam A.F., Hidayat R., Wangge G. |
International Journal of Risk and Safety in Medicine |
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100509044&doi=10.3233%2fJRS-200008&partnerID=40&md5=54ae75564e4436f8e65f2444aa1a5e10 |
306 |
Q3 |
14617 |
|
|
563 |
32067462200 |
Wawaimuli Arozal |
Dr. dr. Wawaimuli Arozal, M.Biomed., Pharm.D. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S2) |
Clinical characteristics of recurrent tuberculosis patients from a Jakarta hospital-based survey |
2021 |
Arozal W., Diliana D., Wikanendra G.B., Purwantyastuti P., Rusli A. |
Journal of the Pakistan Medical Association |
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85109803544&partnerID=40&md5=629bb068125f26ed38057da8c963846e |
242 |
Q4 |
17081 |
|
|
604 |
32067462200 |
Wawaimuli Arozal |
Dr. dr. Wawaimuli Arozal, M.Biomed., Pharm.D. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S2) |
Curcumin Nanoparticle Enhances the Anticancer Effect of Cisplatin by Inhibiting PI3K/AKT and JAK/STAT3 Pathway in Rat Ovarian Carcinoma Induced by DMBA |
2021 |
Sandhiutami N.M.D., Arozal W., Louisa M., Rahmat D., Wuyung P.E. |
Frontiers in Pharmacology |
10 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100565118&doi=10.3389%2ffphar.2020.603235&partnerID=40&md5=5b5af16fb791027b3a94b95b0b6da88b |
1384 |
Q1 |
2619 |
|
|
632 |
32067462200 |
Wawaimuli Arozal |
Dr. dr. Wawaimuli Arozal, M.Biomed., Pharm.D. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S2) |
Mangiferin Attenuates Doxorubicin-Induced Nephrotoxicity in Rats Through Reduction of Oxidative Stress |
2021 |
Arozal W., Barinda A.J., Monayo E.R., Aulia R. |
Journal of International Dental and Medical Research |
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85123841744&partnerID=40&md5=1da2ad818beb007235cddc77a1b487fe |
259 |
Q3 |
16312 |
|
|